Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AML-12 pediatric de novo AML induction trial
jRCTs041180128Phase 3Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cytarabine in acute myeloid leukemia (AML) (2 arms), sponsored by Ministry of Health, Labour and Welfare. Primary endpoints: Early death rate, 3-year event-free survival rate and 1 more. Started Apr 2014; status: completed.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on jRCTs041180128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180128.